Personal information

No personal information available

Activities

Collapse all

Works (47)

A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors

The Oncologist
2025-01-17 | Journal article
DOI: 10.1093/oncolo/oyae364
Contributors: Kimberly Perez; Matthew H Kulke; Hui Zheng; Jill Allen; Jeffrey Clark; Andrea C Enzinger; Peter C Enzinger; Bruce E Johnson; Nadine J McCleary; Aparna Parikh et al.
Source: check_circle
Crossref

A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

Clinical Cancer Research
2025-01-06 | Journal article
DOI: 10.1158/1078-0432.CCR-24-1867
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

Data from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

2025-01-06 | Preprint
DOI: 10.1158/1078-0432.c.7611452
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

Supplementary Figure S1 from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

2025-01-06 | Preprint
DOI: 10.1158/1078-0432.28141931
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

Supplementary Figure S2 from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

2025-01-06 | Preprint
DOI: 10.1158/1078-0432.28141928
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

Supplementary Figure S3 from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

2025-01-06 | Preprint
DOI: 10.1158/1078-0432.28141925
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

Supplementary Figure S4 from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

2025-01-06 | Preprint
DOI: 10.1158/1078-0432.28141922
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

Supplementary Table S1 from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

2025-01-06 | Preprint
DOI: 10.1158/1078-0432.28141919
Contributors: Gregory M. Cote; Bose S. Kochupurakkal; Khanh Do; Andrea Bullock; Michael L. Cheng; Alona Muzikansky; Daniel E. McLoughlin; James M. Cleary; Xin Gao; Aparna Parikh et al.
Source: check_circle
Crossref

A standing platform for cancer drug development using ctDNA-based evidence of recurrence

Nature Reviews Cancer
2024-11 | Journal article
DOI: 10.1038/s41568-024-00742-2
Contributors: Arielle J. Medford; Ariel B. Carmeli; Alexandra Ritchie; Nikhil Wagle; Levi Garraway; Eric S. Lander; Aparna Parikh
Source: check_circle
Crossref

Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer

The Oncologist
2024-11-12 | Journal article
DOI: 10.1093/oncolo/oyae269
Contributors: Leontios Pappas; Julia C F Quintanilha; Richard S P Huang; Aparna R Parikh
Source: check_circle
Crossref

Genomic landscape of head and neck cancer in Asia: A comprehensive meta-analysis of 1016 samples

Oral Oncology Reports
2024-09 | Journal article
DOI: 10.1016/j.oor.2024.100628
Contributors: Srikanth S. Manda; Nafisa Arfa; Neha Sharma; Aparna R. Parikh; Thomas J. Roberts; Sewanti Limaye; Venkataraman Ramachandran; Kumar Prabhash; Moni A. Kuriakose; Prashant Kumar
Source: check_circle
Crossref

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours

Nature Reviews Cancer
2024-07 | Journal article
DOI: 10.1038/s41568-024-00705-7
Contributors: Ashley M. Holder; Aikaterini Dedeilia; Kailan Sierra-Davidson; Sonia Cohen; David Liu; Aparna Parikh; Genevieve M. Boland
Source: check_circle
Crossref

Data from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.c.7348743.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Data from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.c.7348743
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Clinical Cancer Research
2024-07-15 | Journal article
DOI: 10.1158/1078-0432.CCR-23-3660
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302446.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302446
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302443
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302443.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302440
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302440.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302437
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302437.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Table S1 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302434
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Table S1 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302434.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Table S2 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302431.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Table S2 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302431
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Table S3 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302428
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Supplementary Table S3 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

2024-07-15 | Preprint
DOI: 10.1158/1078-0432.26302428.v1
Contributors: Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia A. Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer et al.
Source: check_circle
Crossref

Data from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.c.7209110
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Data from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.c.7209110.v1
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Clinical Cancer Research
2024-05-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-3135
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Supplementary Material 1 from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.25728644.v1
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Supplementary Material 1 from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.25728644
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Recent Advances in the Management of Anal Cancer

Healthcare
2023-11-21 | Journal article
DOI: 10.3390/healthcare11233010
Contributors: Laxmi Upadhyay; Michelle Hartzell; Aparna R. Parikh; Matthew R. Strickland; Samuel Klempner; Midhun Malla
Source: check_circle
Crossref

Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing

JCO Precision Oncology
2023-09 | Journal article
DOI: 10.1200/PO.23.00228
Contributors: Stefania Napolitano; Aparna R. Parikh; Jason Henry; Christine M. Parseghian; Jason Willis; Kanwal P. Raghav; Van K. Morris; Benny Johnson; Bryan K. Kee; Arvind N. Dasari et al.
Source: check_circle
Crossref

Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic Review

JCO Precision Oncology
2023-08 | Journal article
DOI: 10.1200/PO.23.00182
Contributors: Sakti Chakrabarti; Udhayvir Singh Grewal; Kruti Bhagirath Vora; Aparna Raj Parikh; Diana Almader-Douglas; Amit Mahipal; Mohamad (Bassam) B. Sonbol
Source: check_circle
Crossref

Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors

Cancer
2023-06-15 | Journal article
DOI: 10.1002/cncr.34730
Contributors: Meghan J. Mooradian; James M. Cleary; Anita Giobbie‐Hurder; Lancia N. F. Darville; Aparna Parikh; Elizabeth I. Buchbinder; Justine V. Cohen; Donald P. Lawrence; Geoffrey I. Shapiro; Harold Keer et al.
Source: check_circle
Crossref

The emerging promise of liquid biopsies in solid tumors

Nature Cancer
2022-12-20 | Journal article
DOI: 10.1038/s43018-022-00498-4
Contributors: Leontios Pappas; Viktor A. Adalsteinsson; Aparna R. Parikh
Source: check_circle
Crossref

Supportive Oncology Care at Home Intervention for Patients With Pancreatic Cancer

JCO Oncology Practice
2022-10 | Journal article
DOI: 10.1200/OP.22.00088
Contributors: Ryan D. Nipp; Eva Gaufberg; Charu Vyas; Chinenye Azoba; Carolyn L. Qian; Jordon Jaggers; Colin D. Weekes; Jill N. Allen; Eric J. Roeland; Aparna R. Parikh et al.
Source: check_circle
Crossref

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

Journal of Clinical Oncology
2022-08-20 | Journal article
DOI: 10.1200/JCO.21.02615
Contributors: Midhun Malla; Jonathan M Loree; Pashtoon Murtaza Kasi; Aparna Raj Parikh
Source: check_circle
Crossref

Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial

Nature Cancer
2021-11-18 | Journal article
DOI: 10.1038/s43018-021-00269-7
Contributors: Aparna R. Parikh; Annamaria Szabolcs; Jill N. Allen; Jeffrey W. Clark; Jennifer Y. Wo; Michael Raabe; Hannah Thel; David Hoyos; Arnav Mehta; Sanya Arshad et al.
Source: check_circle
Crossref

Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience

The Oncologist
2021-09-01 | Journal article
DOI: 10.1002/onco.13802
Contributors: Gustavo C. L. Gössling; Márcio F. Chedid; Fernando S. Pereira; Rafaela K. Silva; Leonardo B. Andrade; Nícolas Peruzzo; Maurício G. Saueressig; Gilberto Schwartsmann; Aparna R. Parikh
Source: check_circle
Crossref

Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer

JCO Precision Oncology
2020-11 | Journal article
DOI: 10.1200/PO.20.00117
Contributors: Marko Velimirovic; Dejan Juric; Andrzej Niemierko; Laura Spring; Neelima Vidula; Seth A. Wander; Arielle Medford; Aparna Parikh; Giuliana Malvarosa; Megan Yuen et al.
Source: check_circle
Crossref

Results and molecular correlates from a pilot study of neoadjuvant induction FOLFIRINOX followed by chemoradiation and surgery for gastroesophageal adenocarcinomas

2020-11-09 | Preprint
DOI: 10.21203/rs.3.rs-92371/v1
Contributors: Jennifer Wo; Jeffrey Clark; Christine Eyler; Mari Mino-Kenudson; Samuel Klempner; Jill Allen; Florence Keane; Aparna Parikh; Eric Roeland; Lorraine Drapek et al.
Source: check_circle
Crossref

Radiation Induced Checkpoint Immunotherapy Response in Refractory Colorectal and Pancreatic Adenocarcinoma

2020-09-01 | Preprint
DOI: 10.21203/rs.3.rs-58489/v1
Contributors: Aparna Parikh; Annamaria Szabolcs; Jill Allen; Jeffrey Clark; Jennifer Wo; Hannah Thel; David Hoyos; Arnav Mehta; Sanya Arshad; David Lieb et al.
Source: check_circle
Crossref

The Unintentional Perpetuation of the Gender Divide

Journal of General Internal Medicine
2020-03-21 | Journal article
DOI: 10.1007/s11606-019-05360-5
Contributors: Aparna R. Parikh; David A. Asch; Katrina Armstrong
Source: check_circle
Crossref

Peer review (9 reviews for 4 publications/grants)

Review activity for Cell reports medicine. (2)
Review activity for Nature cancer. (1)
Review activity for Nature communications (5)
Review activity for Nature medicine. (1)
How many people are using ORCID?